Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients

被引：0
|
作者：
Yin, S. M. [1 ]
Chen, C. L. [1 ]
Lin, C. C. [1 ]
Wang, C. C. [1 ]
Wang, S. H. [1 ]
Liu, Y. W. [1 ]
Yong, C. C. [1 ]
Lin, T. L. [1 ]
Li, W. F. [1 ]
Lin, Y. H. [1 ]
Chan, Y-C [1 ]
Yeh, C-S [1 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Gen Surg, Kaohsiung, Taiwan
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-59
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [21] Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma
    Pinero, Federico
    Mendizabal, Manuel
    Ridruejo, Ezequiel
    Wolff, Fernando Herz
    Ameigeiras, Beatriz
    Anders, Margarita
    Schinoni, Maria Isabel
    Reggiardo, Virginia
    Palazzo, Ana
    Videla, Maria
    Alonso, Cristina
    Santos, Luisa
    Varon, Adriana
    Figueroa, Sebastian
    Vistarini, Cecilia
    Adrover, Raul
    Fernandez, Nora
    Perez, Daniela
    Tanno, Federico
    Hernandez, Nelia
    Sixto, Marcela
    Borzi, Silvia
    Bruno, Andres
    Cocozzella, Daniel
    Soza, Alejandro
    Descalzi, Valeria
    Estepo, Claudio
    Zerega, Alina
    de Araujo, Alexandre
    Cheinquer, Hugo
    Silva, Marcelo
    Barreyro, F.
    Billordo, A.
    Caballini, P.
    Carbonetti, R.
    Ceballos, S.
    Deltrozzo, V
    Gadea, C.
    Garraztazul, P.
    Garrocho, C.
    Manero, E.
    Mendoza, C.
    Mengarelli, S.
    Moreno, V
    Peralta, M.
    Ratusnu, N.
    Romero, G.
    Ruf, A.
    Tanno, M.
    Tanno, F.
    LIVER INTERNATIONAL, 2019, 39 (06) : 1033 - 1043
  • [22] The effect of direct-acting antivirals on hepatocellular carcinoma recurrence: still waiting for the turning point
    Serviddio, Gaetano
    Villani, Rosanna
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (05) : 525 - 526
  • [23] Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
    Syed, Taseen
    Fazili, Javid
    Ali, Ijlal Akbar
    Zhao, Daniel
    Hughes, Diane
    Mahmood, Sultan
    CUREUS, 2018, 10 (06):
  • [24] Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals
    Caviglia, Gian Paolo
    Troshina, Giulia
    Santaniello, Umberto
    Rosati, Giulia
    Bombaci, Francesco
    Birolo, Giovanni
    Nicolosi, Aurora
    Saracco, Giorgio Maria
    Ciancio, Alessia
    CANCERS, 2022, 14 (03)
  • [25] Correlation Between Vascular Endothelial Growth Factor and Long-Term Occurrence of HCV-Related Hepatocellular Carcinoma After Treatment with Direct-Acting Antivirals
    Ramadan, Haidi K.
    Meghezel, El-Zahraa M.
    Abdel-Malek, Mohammed O.
    Askar, Ashraf A.
    Hetta, Helal F.
    Mahmoud, Amal A.
    Abdel-Aal, Amal M.
    CANCER INVESTIGATION, 2021, 39 (08) : 653 - 660
  • [26] HCV genotypes and serum RNA levels in HCV-related cirrhosis with or without hepatocellular carcinoma (HCC).
    Adinolfi, LE
    Utili, R
    Andreana, A
    Ragone, E
    Cristiano, F
    Tonziello, A
    Mormone, G
    Gambardella, M
    Bellopede, P
    Rosario, P
    Marrone, A
    Ruggiero, G
    HEPATOLOGY, 1996, 24 (04) : 107 - 107
  • [27] Incidence and Risk Factors for Hepatocellular Carcinoma in a Brazilian Cohort of HCV-Related Cirrhotic Patients Treated with Direct-Acting Antiviral Agents
    Cheinquer, Hugo
    De Maman, Italo, Jr.
    De Araujo, Alexandre
    Wolff, Fernando
    Coelho-Borges, Silvia
    Kowacs, Julia
    HEPATOLOGY, 2018, 68 : 391A - 391A
  • [28] Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
    Rodia, R.
    Meloni, P. E.
    Mascia, C.
    Balestrieri, C.
    Ruggiero, V
    Serra, G.
    Conti, M.
    Loi, M.
    Pes, F.
    Onali, S.
    Perra, A.
    Littera, R.
    Velluzzi, F.
    Mariotti, S.
    Chessa, L.
    Boi, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2023, 46 (02) : 359 - 366
  • [29] Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
    R. Rodia
    P. E. Meloni
    C. Mascia
    C. Balestrieri
    V. Ruggiero
    G. Serra
    M. Conti
    M. Loi
    F. Pes
    S. Onali
    A. Perra
    R. Littera
    F. Velluzzi
    S. Mariotti
    L. Chessa
    F. Boi
    Journal of Endocrinological Investigation, 2023, 46 : 359 - 366
  • [30] HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
    Emamaullee, Juliet A.
    Bral, Mariusz
    Meeberg, Glenda
    Montano-Loza, Aldo J.
    Bain, Vincent G.
    Burak, Kelly Warren
    Bigam, David
    Shapiro, A. M. James
    Kneteman, Norman
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 2019
12345